Cerebral open flow microperfusion (cOFM) an innovative interface to brain tissue-Reference-Cited by-同舟云学术

Cerebral open flow microperfusion (cOFM) an innovative interface to brain tissue

Published:2016-06 Issue: Volume:20 Page:19-25
ISSN:1740-6749
Container-title:Drug Discovery Today: Technologies
language:en
Short-container-title:Drug Discovery Today: Technologies

Author:

Birngruber Thomas,Sinner Frank

Funder

Austrian Research Promotion Agency

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference43 articles.

1. Blood–brain barrier structure and function and the challenges for CNS drug delivery;Abbott;J Inherit Metab Dis,2013

2. Prediction of blood–brain barrier permeation in drug discovery from in vivo, in vitro and in silico models;Abbott;Drug Discov Today Technol,2004

3. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives;Chaurasia;Pharm Res,2007

4. Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion;Dragatin;Exp Dermatol,2015

5. Open flow microperfusion: pharmacokinetics of human insulin and insulin detemir in the interstitial fluid of subcutaneous adipose tissue;Höfferer;Diabetes Obes Metab,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic Interfaces for Chronic Bidirectional Access to the Brain;Advanced Healthcare Materials;2024-06-26

2. Implementation and validation of a UHPLC-MS/MS method for quantification of the endocannabinoids AEA and 2-AG in cerebral interstitial fluid and plasma;Journal of Pharmaceutical and Biomedical Analysis;2024-01

3. Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig Model;Pharmaceutical Research;2023-12-29

4. Microfluidic interfaces for chronic bidirectional access to the brain;2023-09-22

5. Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity;Pharmaceutics;2023-07-04